about axogen
management team
board of directors
careers
partners
esg report
code of ethics and conduct
patents
investors
news
contact
find a rep
international distributors
find referring surgeon
healthcare professionals
patients
Investors
Overview
News / Events
Overview
Press Releases
Axogen In the News
IR Calendar
ESG Report
Clinical Conferences
Presentations
Email Alerts
Financial Info
Overview
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Current Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Contact the Board
Additional Info
Contacts
FAQ
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
All SEC Filings
Filing Type:
View All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
144
3
3/A
4
4/A
424B2
424B3
424B4
424B5
425
5
5/A
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
EFFECT
NT 10-K
NT 10-Q
POS AM
POS EX
POSASR
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
Date
Form
Description
PDF
XBRL
Pages
09/28/11
4
Statement of changes in beneficial ownership of securities
2
09/28/11
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
09/09/11
10-Q/A
Quarterly report pursuant to Section 13 or 15(d)
6
09/06/11
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Documents
EX-99.1
6
09/06/11
8-K
Current report filing
Documents
EX-99.1
6
09/02/11
EFFECT
Notice of Effectiveness
1
09/02/11
424B3
Prospectus filed pursuant to Rule 424(b)(3)
344
09/01/11
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
1
08/29/11
CORRESP
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
4
08/29/11
S-4/A
Registration of securities issued in business combination transactions
Documents
EX-10.22
EX-10.23
EX-23.1
EX-23.2
EX-99.1
399
94
95
96
97
98
99
100
101
102
103
You are now leaving axogeninc.com
Axogen is not responsible for content or policies on linked sites.
OK
Cancel